个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
为什么 Geron 股票的交易价格下跌了 13%;这里有 20 只股票在盘前走势
Gainers
- Vyant Bio, Inc. (NASDAQ:VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.
- Humanigen, Inc. (NASDAQ:HGEN) rose 42% to $0.24 in pre-market trading after jumping around 42% on Wednesday.
- Oblong, Inc. (NASDAQ:OBLG) shares rose 40.7% to $3.11 in pre-market trading after gaining over 26% on Wednesday. Oblong announced a 1-for-15 reverse stock split.
- Argo Blockchain plc (NASDAQ:ARBK) rose 37.4% to $1.65 in pre-market trading. Roth Capital, on Wednesday, upgraded Argo Blockchain from Sell to Neutral and raised the price target from $0.25 to $1.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) rose 23.2% to $0.3651 in pre-market trading. Crown Electrokinetics shares jumped 58% on Wednesday after the company announced it acquired Amerigen 7.
- Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) rose 23% to $14.15 in pre-market trading.
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 20.4% to $4.82 in pre-market trading after gaining around 18% on Wednesday. Kiora Pharmaceuticals recently completed enrollment of clinical trial evaluating KIO-201 for persistent corneal epithelial defects.
- AMTD IDEA Group (NYSE:AMTD) shares rose 18.2% to $1.94 in pre-market trading. AMTD IDEA Group, during November, announced 1-for-2 ADS ratio change.
- Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) rose 15.5% to $0.1271 in pre-market trading.
- JanOne Inc. (NASDAQ:JAN) rose 14.4% to $1.74 in pre-market trading. JanOne said effective as of December 28, 2022, the company acquired Soin Therapeutics.
Losers
- Vivos Therapeutics, Inc. (NASDAQ:VVOS) fell 17.5% to $1.55 in pre-market trading. Vivos Therapeutics shares jumped 154% on Wednesday after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.
- Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares fell 16% to $0.2436 in pre-market trading after dropping over 6% on Wednesday. Dermata Therapeutics recently requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
- Nuwellis, Inc. (NASDAQ:NUWE) fell 14.3% to $9.38 in pre-market trading. Nuwellis announced passage of warrant proposal.
- Geron Corporation (NASDAQ:GERN) shares fell 12.9% to $2.78 in pre-market trading after the company announced a proposed public offering.
- Jasper Therapeutics, Inc. (NASDAQ:JSPR) fell 10.3% to $1.92 in pre-market trading after dropping 22% on Wednesday. Jasper Therapeutics announced European Union Orphan Drug Designation for Briquilimab as a conditioning treatment for patients prior to receiving a stem cell transplant.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) fell 10.1% to $1.96 in pre-market trading. InMed, last month, announced appointment of interim Chief Financial Officer and change of auditor.
- Atlis Motor Vehicles, Inc. (NASDAQ:AMV) fell 9.5% to $3.30 in pre-market trading. Altis Motor Vehicles filed for offering of up to 20.46 million shares of class A common stock by selling stockholders.
- Cryptyde, Inc. (NASDAQ:TYDE) fell 9.2% to $0.3175 in pre-market trading after jumping 81% on Wednesday. Cryptyde announced 2023 corporate priorities for the next 12 months.
- TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 9% to $4.45 in pre-market trading after jumping 25% on Wednesday. TC BioPharm, last month, posted 1H EPS of $1.13.
- Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 6.9% to $0.31 in pre-market trading after gaining over 4% on Wednesday.
Gainers
获胜者
- Vyant Bio, Inc. (NASDAQ:VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.
- Humanigen, Inc. (NASDAQ:HGEN) rose 42% to $0.24 in pre-market trading after jumping around 42% on Wednesday.
- Oblong, Inc. (NASDAQ:OBLG) shares rose 40.7% to $3.11 in pre-market trading after gaining over 26% on Wednesday. Oblong announced a 1-for-15 reverse stock split.
- Argo Blockchain plc (NASDAQ:ARBK) rose 37.4% to $1.65 in pre-market trading. Roth Capital, on Wednesday, upgraded Argo Blockchain from Sell to Neutral and raised the price target from $0.25 to $1.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) rose 23.2% to $0.3651 in pre-market trading. Crown Electrokinetics shares jumped 58% on Wednesday after the company announced it acquired Amerigen 7.
- Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) rose 23% to $14.15 in pre-market trading.
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 20.4% to $4.82 in pre-market trading after gaining around 18% on Wednesday. Kiora Pharmaceuticals recently completed enrollment of clinical trial evaluating KIO-201 for persistent corneal epithelial defects.
- AMTD IDEA Group (NYSE:AMTD) shares rose 18.2% to $1.94 in pre-market trading. AMTD IDEA Group, during November, announced 1-for-2 ADS ratio change.
- Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) rose 15.5% to $0.1271 in pre-market trading.
- JanOne Inc. (NASDAQ:JAN) rose 14.4% to $1.74 in pre-market trading. JanOne said effective as of December 28, 2022, the company acquired Soin Therapeutics.
- Vyant Bio, Inc. 纳斯达克股票代码:VYNT)的股价在盘前交易中上涨了110.4%,至1.62美元,此前该公司表示已聘请LifeSci Capital作为其顾问来探索战略替代方案。
- Humanigen, Inc. 纳斯达克股票代码:HGEN)在周三上涨约42%后,在盘前交易中上涨了42%,至0.24美元。
- Oblong, Inc. 纳斯达克股票代码:OBLG)股价在周三上涨超过26%之后,在盘前交易中上涨了40.7%,至3.11美元。Oblong宣布以1比15的比例进行反向股票分割。
- Argo 区块链有限公司 纳斯达克股票代码:ARBK)在盘前交易中上涨37.4%,至1.65美元。Roth Capital周三将Argo区块链从卖出上调至中性,并将目标价格从0.25美元上调至1美元。
- 皇冠电动动力学公司 纳斯达克股票代码:CRKN)在盘前交易中上涨23.2%,至0.3651美元。在公司宣布收购Amerigen 7后,Crown Electrokinetics的股价周三上涨了58%。
- Arbor Rapha Capital 生物控股公司 I 纳斯达克股票代码:ARCK)在盘前交易中上涨23%,至14.15美元。
- Kiora 制药有限公司 纳斯达克股票代码:KPRX)在周三上涨约18%之后,在盘前交易中上涨了20.4%,至4.82美元。Kiora Pharmicals 最近完成了评估 KIO-201 是否存在持续角膜上皮缺陷的临床试验的注册。
- 尚乘创意集团 纽约证券交易所代码:AMTD)股价在盘前交易中上涨18.2%,至1.94美元。尚乘IDEA集团在11月宣布调整ADS比率为1比2。
- Powerbridge Technologies 纳斯达克股票代码:PBTS)在盘前交易中上涨15.5%,至0.1271美元。
- JanOne Inc. 纳斯达克股票代码:JAN)在盘前交易中上涨14.4%,至1.74美元。JanOne表示,自2022年12月28日起,该公司收购了Soin Therapeutics。
Losers
失败者
- Vivos Therapeutics, Inc. (NASDAQ:VVOS) fell 17.5% to $1.55 in pre-market trading. Vivos Therapeutics shares jumped 154% on Wednesday after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.
- Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares fell 16% to $0.2436 in pre-market trading after dropping over 6% on Wednesday. Dermata Therapeutics recently requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
- Nuwellis, Inc. (NASDAQ:NUWE) fell 14.3% to $9.38 in pre-market trading. Nuwellis announced passage of warrant proposal.
- Geron Corporation (NASDAQ:GERN) shares fell 12.9% to $2.78 in pre-market trading after the company announced a proposed public offering.
- Jasper Therapeutics, Inc. (NASDAQ:JSPR) fell 10.3% to $1.92 in pre-market trading after dropping 22% on Wednesday. Jasper Therapeutics announced European Union Orphan Drug Designation for Briquilimab as a conditioning treatment for patients prior to receiving a stem cell transplant.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) fell 10.1% to $1.96 in pre-market trading. InMed, last month, announced appointment of interim Chief Financial Officer and change of auditor.
- Atlis Motor Vehicles, Inc. (NASDAQ:AMV) fell 9.5% to $3.30 in pre-market trading. Altis Motor Vehicles filed for offering of up to 20.46 million shares of class A common stock by selling stockholders.
- Cryptyde, Inc. (NASDAQ:TYDE) fell 9.2% to $0.3175 in pre-market trading after jumping 81% on Wednesday. Cryptyde announced 2023 corporate priorities for the next 12 months.
- TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 9% to $4.45 in pre-market trading after jumping 25% on Wednesday. TC BioPharm, last month, posted 1H EPS of $1.13.
- Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 6.9% to $0.31 in pre-market trading after gaining over 4% on Wednesday.
- Vivos Therapeutics, 纳斯达克股票代码:VVOS)在盘前交易中下跌17.5%,至1.55美元。Vivos Therapeutics的股价周三上涨了154%,此前该公司宣布其用于治疗阻塞性睡眠呼吸暂停的DNA口服器具已获得美国食品药品管理局510(k)许可。
- Dermata Therapeutics, Inc 纳斯达克股票代码:DRMA)股价在周三下跌超过6%后,在盘前交易中下跌了16%,至0.2436美元。Dermata Therapeutics最近要求撤回其在S-1表格上的注册,并表示不打算进行所设想的公开发行。
- Nuwellis, Inc. 纳斯达克股票代码:NUWE)在盘前交易中下跌14.3%,至9.38美元。努韦利斯宣布通过逮捕令提案。
- 杰龙公司 纳斯达克股票代码:GERN)宣布拟议的公开募股后,股价在盘前交易中下跌12.9%,至2.78美元。
- Jasper Therapeutics, In 纳斯达克股票代码:JSPR)在周三下跌22%后,在盘前交易中下跌了10.3%,至1.92美元。Jasper Therapeutics宣布将Briquilimab指定为欧盟孤儿药,作为患者在接受干细胞移植前的调理治疗。
- InMed 制药公司 纳斯达克股票代码:INM)在盘前交易中下跌10.1%,至1.96美元。InMed上个月宣布任命临时首席财务官和更换审计师。
- 阿特利斯汽车有限公司 纳斯达克股票代码:AMV)在盘前交易中下跌9.5%,至3.30美元。Altis Motor Vehicles申请通过出售股东发行高达2046万股A类普通股。
- Cryptyde, Inc. 纳斯达克股票代码:TYDE)在周三上涨81%后,在盘前交易中下跌9.2%,至0.3175美元。Cryptyde宣布了未来12个月的2023年企业优先事项。
- TC Biopharm(控股)有限公司 纳斯达克股票代码:TCBP)在周三上涨了25%之后,在盘前交易中下跌了9%,至4.45美元。TC BioPharm上个月公布的上半年每股收益为1.13美元。
- Plus Therapeutics 纳斯达克股票代码:PSTV)在周三上涨超过4%后,在盘前交易中下跌6.9%,至0.31美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!